POONGJEON PHARMACY (298060) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, POONGJEON PHARMACY (298060) reported revenue of 23.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202523.8 billion KRW-4.5 billion KRW203 million KRW[source]
2024825 million KRW-11.3 billion KRW-12.4 billion KRW[source]
2023696 million KRW-13.0 billion KRW-24.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202542.2 billion KRW8.3 billion KRW34.0 billion KRW[source]
202423.2 billion KRW9.0 billion KRW14.2 billion KRW[source]
202325.4 billion KRW4.9 billion KRW20.5 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice